🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed weight-reducing properties. Viewers are encouraged to message these accounts privately for source information, while also receiving promotional offers.

Active Commerce on Social Networks

Separately, a robust market exists on messaging services, where groups with thousands of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Vendors market the drug there before directing customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Early trials suggest it could assist patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.

Medical Experts Voice Worries

However, doctors and chemists have warned that the sale of what is still an unlicensed medication in the UK is worrisome and could lead to individuals administering products of unknown origin.

Several professionals said the demand for retatrutide could be connected to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, advertising, and customer laws, potentially leading to penalties, legal action or prison.

Platform Response and Content Removal

According to the social media company, the service has taken down problematic content and banned associated hashtags and query recommendations. The company stated it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.

Digital Trading Activities

Research also discovered groups with up to nine thousand members selling the experimental drug using the platform's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly displays channels with thousands of members, filled with photos of slimming results, glowing reviews and step-by-step instructions for mixing or administering at residence.

After moments of entering one community, a seller shared WhatsApp details, where the majority of transactions occur. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged testing documentation. None inquired about body mass, health issues or past usage.

Item Information and Pricing

Inside these groups, posts display dark colored parcels with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at residence with purified liquid, or ready-to-use injectors usually sold at £160 for 20mg. When asked how long a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Platform Moderation and Safety Measures

A representative for the messaging service stated it regularly moderated harmful material on its service including material that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they cannot confirm. Even if the science behind this drug is sound, these digital versions may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service linked the increase in interest to current price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, patients are turning to online platforms. But fake injections are highly dangerous. You cannot know what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has already seen individuals injured by personal administration from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “falsely representing itself as a company investigational product not yet authorized … may subject patients to possibly serious medical dangers”.